Cryologics, Inc. Newsletter

 

February 2013

Greetings!

 

Welcome to the February 2013 issue of our e-newsletter!  In this issue, we present the latest PMF Newsletter and a spotlight on Cryologics' President Bob Westney's presentation for the upcoming CETA annual meeting.

 

PMF LogoPharmaceutical Microbiology Forum (PMF) Newsletter
February 2013

In the latest issue of the PMF Newsletter, Dr. Michael Miller discusses the current state of Rapid Microbiological Methods (RMMs).  His discussion includes Quality, regulatory and validation considerations.  Dr. Tim Sandle also presents an article addressing the variability of the Limulus amebocyte lysate (LAL) assay.  Dr. Sandle discusses each area, and provides recommendations for statistical analyses.

Join the PMFList to participate in informative discussions of current topics in cGMP Microbiology. It's free!

CETA 21st Annual MeetingCETA   
Orlando, Florida
April 12-16, 2013
Cryologics' President Bob Westney will be presenting at the Controlled Environment Testing Association's (CETA) 21st Annual Meeting.  His presentation will be "A Risk-Based Approach for Investigating Environmental Monitoring Excursions".  Many other well-known industry experts, including Ed Balkovic and Jeanne Moldenhauer, will also be presenting at this conference, providing invaluable information for industry microbiologists.  This is a "don't miss" event, and we invite you to attend.
  

Contact us today!

 

info@cryologics.com

www.cryologics.com

(610) 847-8781

 

In This Issue
PMF February 2013 Newsletter
CETA 21st Annual Meeting
Product Spotlight
CryoLC(R)  
PRODUCT SPOTLIGHT

Our CryoLC® and CryoHC® products are your cost-effective solution to preparing your in-house microbial isolates for use in compendial testing.

  

* No advance planning. Ready in minutes. Simply thaw, mix and aliquot.

 

* Eliminate the time and resources needed to prepare your organisms.

 

* Lowest cost and lead time in the industry.

 

* Straightforward pricing.  No hidden or non-refundable fees.

 

* Eliminate your risk of regulatory non-compliance.

 

 

View our profile on LinkedIn